Positron emission tomographic imaging of pleomorphic adenoma in the parotid gland

Acta Oto-Laryngologica, Supplement

Volumn , Issue 538, 1998, Pages 214-220

  Matsuda, Miki ^a   Sakamoto, Hirokazu ^a   Okamura, Terue ^a   Nakai, Yoshiaki ^a   Ohashi, Yoshihiro ^a   Kawabe, Joji ^a   Ochi, Hironobu ^a   Wakasa, Kenichiro ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 18F 2 deoxy D glucose (FDG); Parotid gland; Pleomorphic adenoma; Positron emission tomography (PET)

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND TUMOR; PLEOMORPHIC ADENOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; SCINTILLATION; TUMOR CLASSIFICATION; TUMOR VOLUME; WARTHIN TUMOR; AGED; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADENOMA, PLEOMORPHIC; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PAROTID NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031593528     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eneroth C-M. Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer 1971; 27: 1415-8.
2. Seifert G, Sobin LH. Histological typing of salivary gland tumors, 2nd. Berlin: Springer-Verlag, 1991.
3. Yoshikai T, Yonemitu N, Ishimaru J, Mihara M, Shin T, Kudo S. Pleomorphic adenoma of the salivary glands: correlation between Gallium-67 uptake and histopathological components. J Nucl Med 1998; 39: 537-41.
4. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-48.
5. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997; 27: 94-106.
6. 18F] 2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-88.
7. Okamura T, Kawabe J, Hosokawa T, et al. FDG-PET studies of head and neck lesions. In: Ochi H, Konishi J, Yonekura Y, Fukichi M, Nishimura T, Tamaki N, eds. Brain, heart and tumor imaging: updated PET and MRI. Proceedings of the 2nd International Osaka City University Symposium, Osaka, Japan, 2-4 October 1994. Elsevier Science, 1995: 139-48.
8. Warburg O. On the origins of cancer cells. Science 1956; 123: 309-14.
9. Keyes Jr JW, Harkness B, Greven K, Williams D, Watson N, McGuirt W. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994; 192: 99-102.
10. Horiuchi M, Yasuda S, Shohtsu A, et al. Four cases of Warthin's tumor of the parotid gland detected with FDG-PET. Ann Nucl Med 1998; 12: 47-50.
11. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Org 1990; 24: 606-9.
12. Sakamoto H, Nakai Y, Ohashi Y, Okamura T, Ochi H. Positron emission tomographic imaging of head and neck lesions. Eur Arch Otorhinolaryngol 1997; 254 (Suppl 1): 123-6.
13. Renehan A, Gleave EN, McGurk M. An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland. Am J Surg 1996; 172: 710-4.
14. Haberkorn U, Straus LG, Reisser CH, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of flow cytometry. J Nucl Med 1991; 32: 1548-55.
15. McGuirt WF, Keyes Jr JW, Greven KM, Williams DW, Watson Jr NE, Cappellari JO. Preoperative identification of benign versus malignant parotid mass: a comparative study including positron emission tomography. Laryngoscope 1995; 105: 579-84.